Targeted therapies in CLL/SLL and the cumulative incidence of infection: A systematic review and meta-analysis

Background: Patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) are prone to infections. Aims: Provide a pooled estimate of the cumulative incidence for infections that fulfilled the criteria associated with severe infectious adverse events for grade 3 or higher (includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassilopoulos, Stephanos, Shehadeh, Fadi, Kalligeros, Markos, Tran, Quynh-Lam, Schiffman, Fred, Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515578/
https://www.ncbi.nlm.nih.gov/pubmed/36188587
http://dx.doi.org/10.3389/fphar.2022.989830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515578/
https://www.ncbi.nlm.nih.gov/pubmed/36188587
http://dx.doi.org/10.3389/fphar.2022.989830

Ejemplares similares